Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications
Abu-Alfa A, Atallah P, Azar S, Dagher E, Echtay A, El-Amm M, Hazkial H, Kassab R, Medlej R, Mohamad M. Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications. Diabetes Therapy 2022, 14: 11-28. PMID: 36517708, PMCID: PMC9880119, DOI: 10.1007/s13300-022-01340-x.Peer-Reviewed Original ResearchType 2 diabetesGlycemic statusGlucagon-like peptide-1 receptor agonistsSodium-glucose cotransporter 2 inhibitorsMajor randomized clinical trialsPeptide-1 receptor agonistsCardio-renal benefitsCardio-renal complicationsMultifactorial risk assessmentCotransporter 2 inhibitorsGlucose-lowering agentsIndividualized management planDisease-modifying drugsPrevalence of T2DRandomized clinical trialsPatient's glycemic statusFavorable health outcomesMedical societiesInternational medical societiesScientific Medical SocietiesGlobal health problemAppropriate pharmacological therapyPatient-centered approachLocal medical practiceSuboptimal screening